Advertisement

Tumor Biology

, Volume 37, Issue 11, pp 14335–14340 | Cite as

Signatures of prostate-derived Ets factor (PDEF) in cancer

  • Nitin Mahajan
Review

Abstract

The Ets proteins are a family of transcription factors characterized by an evolutionarily conserved DNA-binding domain and have diverse biological functions including tumor suppressor as well as tumor promoter functions. They are regulated via a complex and diverse number of mechanisms and control key cellular processes. Prostate-derived Ets transcription factor (PDEF), a unique member of the ETS family, is present in tissues with high epithelial content are hormone-regulated, such as prostate, breast, salivary glands, ovaries, colon, airways, and stomach tissues. PDEF (prostate-derived Ets factor) is also referred to as SPDEF (SAM pointed domain containing Ets transcription factor), PSE (mouse homolog), or hPSE (human PSE) in the literature and is the sole member of the PDEF ETS sub-family. The role of PDEF in cancer development is still not fully elucidated though. The present article focuses on the key findings about the PDEF’s biological functions, interacting proteins, and its target genes. There is a strong urge to focus on the clinical studies in larger cohort, which elucidate the regulation of PDEF and its target genes, to determine the potential of PDEF as biomarker. Based on the studies discussed in the present article, one can anticipate that PDEF offers a great potential for developing therapeutics against cancer.

Keywords

PDEF SPDEF PSE Tumor suppressor Cancer 

References

  1. 1.
    Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol. 2001;2:827–37.CrossRefPubMedGoogle Scholar
  2. 2.
    Sood AK, Kim H, Geradts J. PDEF in prostate cancer. Prostate. 2012;72:592–6.CrossRefPubMedGoogle Scholar
  3. 3.
    He J, Pan Y, Hu J, Albarracin C, Wu Y, Dai JL. Profile of Ets gene expression in human breast carcinoma. Cancer biology & therapy. 2007;6:76–82.CrossRefGoogle Scholar
  4. 4.
    Moussa O, Turner DP, Feldman RJ, Sementchenko VI, McCarragher BD, Desouki MM, Fraig M, Watson DK. PDEF is a negative regulator of colon cancer cell growth and migration. J Cell Biochem. 2009;108:1389–98.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Noah TK, Kazanjian A, Whitsett J, Shroyer NF. SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells. Exp Cell Res. 2010;316:452–65.CrossRefPubMedGoogle Scholar
  6. 6.
    Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene. 2003;303:11–34.CrossRefPubMedGoogle Scholar
  7. 7.
    Oettgen P, Finger E, Sun Z, Akbarali Y, Thamrongsak U, Boltax J, Grall F, Dube A, Weiss A, Brown L, Quinn G, Kas K, Endress G, Kunsch C, Libermann TA. PDEF, a novel prostate epithelium-specific Ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J Biol Chem. 2000;275:1216–25.CrossRefPubMedGoogle Scholar
  8. 8.
    Wang Y, Feng L, Said M, Balderman S, Fayazi Z, Liu Y, Ghosh D, Gulick AM. Analysis of the 2.0 a crystal structure of the protein-DNA complex of the human PDEF Ets domain bound to the prostate specific antigen regulatory site. Biochemistry. 2005;44:7095–106.CrossRefPubMedGoogle Scholar
  9. 9.
    Steffan JJ, Koul HK. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor. Cancer Lett. 2011;310:109–17.CrossRefPubMedGoogle Scholar
  10. 10.
    Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS. Novel role for PDEF in epithelial cell migration and invasion. Cancer Res. 2005;65:11572–80.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Johnson TR, Koul S, Kumar B, Khandrika L, Venezia S, Maroni PD, Meacham RB, Koul HK. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF. Mol Cancer. 2010;9:148.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Nozawa M, Yomogida K, Kanno N, Nonomura N, Miki T, Okuyama A, Nishimune Y, Nozaki M. Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells. Cancer Res. 2000;60:1348–52.PubMedGoogle Scholar
  13. 13.
    Turner DP, Findlay VJ, Moussa O, Semenchenko VI, Watson PM, LaRue AC, Desouki MM, Fraig M, Watson DK. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Prostate. 2011;71:1723–35.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Findlay VJ, Turner DP, Moussa O, Watson DK. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res. 2008;68:8499–506.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Chen H, Nandi AK, Li X, Bieberich CJ. NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res. 2002;62:338–40.PubMedGoogle Scholar
  16. 16.
    Chen H, Bieberich CJ. Structural and functional analysis of domains mediating interaction between NKX-3.1 and PDEF. J Cell Biochem. 2005;94:168–77.CrossRefPubMedGoogle Scholar
  17. 17.
    Fowler M, Borazanci E, McGhee L, Pylant SW, Williams BJ, Glass J, Davis JN, Meyers S. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region. J Cell Biochem. 2006;97:1–17.CrossRefPubMedGoogle Scholar
  18. 18.
    Cho JY, Lee M, Ahn JM, Park ES, Cho JH, Lee SJ, Kim BG, Heo SH, Park HJ, Zerbini LF, Hwang D, Libermann TA. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex. J Proteome Res. 2009;8:1327–37.CrossRefPubMedGoogle Scholar
  19. 19.
    Sabherwal Y, Mahajan N, Helseth DL, Gassmann M, Shi H, Zhang M. PDEF downregulates stathmin expression in prostate cancer. Int J Oncol. 2012;40:1889–99.PubMedGoogle Scholar
  20. 20.
    Deves C, Renck D, Garicochea B, da Silva VD, Giulianni Lopes T, Fillman H, Fillman L, Lunardini S, Basso LA, Santos DS, Batista Jr EL. Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer. Virchows Archiv: an international journal of pathology. 2011;458:421–30.Google Scholar
  21. 21.
    Ghadersohi A, Pan D, Fayazi Z, Hicks DG, Winston JS, Li F. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo. Breast Cancer Res Treat. 2007;102:19–30.CrossRefPubMedGoogle Scholar
  22. 22.
    Ghadersohi A, Odunsi K, Zhang S, Azrak RG, Bundy BN, Manjili MH, Li F. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients. International journal of cancer Journal international du cancer. 2008;123:1376–84.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Feldman RJ, Sementchenko VI, Gayed M, Fraig MM, Watson DK. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res. 2003;63:4626–31.PubMedGoogle Scholar
  24. 24.
    Turner DP, Findlay VJ, Kirven AD, Moussa O, Watson DK. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. Mol Biol Cell. 2008;19:3745–57.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Kruger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gansbacher B, Schmitt M. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87). Cancer Gene Ther. 2000;7:292–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Yamada N, Tamai Y, Miyamoto H, Nozaki M. Cloning and expression of the mouse Pse gene encoding a novel Ets family member. Gene. 2000;241:267–74.CrossRefPubMedGoogle Scholar
  27. 27.
    Mahajan N, Shi HY, Lukas TJ, Zhang M. Tumor-suppressive maspin functions as a reactive oxygen species scavenger: importance of cysteine residues. J Biol Chem. 2013;288:11611–20.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Kim S, Han J, Kim J, Park C. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res. 2004;64:6900–5.CrossRefPubMedGoogle Scholar
  29. 29.
    Schaefer JS, Sabherwal Y, Shi HY, Sriraman V, Richards J, Minella A, Turner DP, Watson DK, Zhang M. Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression. J Biol Chem. 2010;285:11258–69.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Thompson HG, Harris JW, Wold BJ, Lin F, Brody JP. p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. Oncogene. 2003;22:2322–33.CrossRefPubMedGoogle Scholar
  31. 31.
    Frietsch JJ, Grunewald TG, Jasper S, Kammerer U, Herterich S, Kapp M, Honig A, Butt E. Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer. Br J Cancer. 2010;102:1645–53.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Sabherwal Y, Mahajan N, Zhang M. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells. Oncol Rep. 2013;30:1985–8.PubMedGoogle Scholar
  33. 33.
    Kim IJ, Kang TW, Jeong T, Kim YR, Jung C. Hoxb13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion. Int J Oncol. 2014;45:869–76.PubMedGoogle Scholar
  34. 34.
    Kim YR, Kim IJ, Kang TW, Choi C, Kim KK, Kim MS, Nam KI, Jung C. HOXB13 downregulates intracellular zinc and increases NF-kappaB signaling to promote prostate cancer metastasis. Oncogene. 2014;33:4558–67.CrossRefPubMedGoogle Scholar
  35. 35.
    Park KS, Korfhagen TR, Bruno MD, Kitzmiller JA, Wan H, Wert SE, Khurana Hershey GK, Chen G, Whitsett JA. SPDEF regulates goblet cell hyperplasia in the airway epithelium. J Clin Invest. 2007;117:978–88.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Chen G, Korfhagen TR, Xu Y, Kitzmiller J, Wert SE, Maeda Y, Gregorieff A, Clevers H, Whitsett JA. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J Clin Invest. 2009;119:2914–24.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Gregorieff A, Stange DE, Kujala P, Begthel H, van den Born M, Korving J, Peters PJ, Clevers H. The ets-domain transcription factor Spdef promotes maturation of goblet and paneth cells in the intestinal epithelium. Gastroenterology. 2009;137:1333–45 .e1331-1333CrossRefPubMedGoogle Scholar
  38. 38.
    Horst D, Gu X, Bhasin M, Yang Q, Verzi M, Lin D, Joseph M, Zhang X, Chen W, Li YP, Shivdasani RA, Libermann TA. Requirement of the epithelium-specific Ets transcription factor Spdef for mucous gland cell function in the gastric antrum. J Biol Chem. 2010;285:35047–55.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Cavazzola LR, Carvalhal GF, Deves C, Renck D, Almeida R, Santos DS. Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue. Oncol Lett. 2015;9:2886–94.PubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  1. 1.Washington University in Saint LouisSaint LouisUSA

Personalised recommendations